<p>IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open an office in Purdue’s Discovery Park District.</p> <p>As the COVID-19 pandemic was about to break around the globe, IdentifySensors, the parent company of IdentifySensors Biologics, had approached Purdue to help it develop a nanosensor designed to detect spoilage and specific pathogens in the food supply chain.</p> <p>When the pandemic became apparent, the company pivoted to start working with Purdue researcher Lia Stanciu, associate head and professor of materials engineering, to develop a rapid diagnostic platform for detecting SARS-CoV-2, the virus that causes COVID-19.</p> <p>IdentifySensors Biologics has partnered with PRF and has opened an office in the Convergence Center for Innovation and Collaboration in Purdue’s Discovery Park District. PRF is investing $50,000 in IdentifySensors.</p>